What does ORTHO - CLINICAL DIAGNOSTICS do?

ORTHO - CLINICAL DIAGNOSTICS is registered with the CBE as active in: Groothandel in farmaceutische producten. Public Limited, started on 12 November 1979, 1 establishment.

What is the address of ORTHO - CLINICAL DIAGNOSTICS?

The registered office of ORTHO - CLINICAL DIAGNOSTICS is located at Da Vincilaan 1, 1930 Zaventem.

Is ORTHO - CLINICAL DIAGNOSTICS still active?

Yes. According to the CBE (16 September 2026) ORTHO - CLINICAL DIAGNOSTICS is active, legal situation “Normale toestand”, started on 12 November 1979.

Is ORTHO - CLINICAL DIAGNOSTICS registered on Peppol?

Yes, ORTHO - CLINICAL DIAGNOSTICS is registered on the Peppol network with ID 0208:0419897954.

What is the enterprise number of ORTHO - CLINICAL DIAGNOSTICS?

The enterprise number of ORTHO - CLINICAL DIAGNOSTICS is BE0419897954.

When was ORTHO - CLINICAL DIAGNOSTICS founded?

ORTHO - CLINICAL DIAGNOSTICS was founded on 12 November 1979.

Who are the directors of ORTHO - CLINICAL DIAGNOSTICS?

According to the 2025 annual accounts, the directors of ORTHO - CLINICAL DIAGNOSTICS are: Jürgen Naudts, Emmanuel Van de Wouwer, Salah Itani, Mikael Julien.

Is ORTHO - CLINICAL DIAGNOSTICS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 November 1979; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did ORTHO - CLINICAL DIAGNOSTICS make in 2025?

ORTHO - CLINICAL DIAGNOSTICS posted a profit after taxes of € 1,418,992 in financial year 2025.

What is the revenue of ORTHO - CLINICAL DIAGNOSTICS?

In its most recent annual accounts (2025), ORTHO - CLINICAL DIAGNOSTICS reported revenue of € 12,721,310.

How much does an employee at ORTHO - CLINICAL DIAGNOSTICS earn?

The average wage cost per full-time employee at ORTHO - CLINICAL DIAGNOSTICS was € 157,700 in 2025: staff costs of € 6.4 million for 40.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ORTHO - CLINICAL DIAGNOSTICS have?

According to the 2025 annual accounts, ORTHO - CLINICAL DIAGNOSTICS has 40.4 full-time equivalents (FTE).

ORTHO - CLINICAL DIAGNOSTICS (Public Limited) - Zaventem

Dossier ORTHO - CLINICAL DIAGNOSTICS, printed on 16 September 2026 from databakkes.be/en/0419897954/ortho-clinical-diagnostics. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

72 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

ORTHO - CLINICAL DIAGNOSTICS from Zaventem, company number BE0419897954, closed financial year 2025 with a result of € 1.4 million after tax. For that financial year ORTHO - CLINICAL DIAGNOSTICS recorded revenue of € 12.7 million and equity of € 11 million. Compared with financial year 2024, the result moved from € 1.1 million to € 1.4 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 11 million

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.4 million

▲ 28% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 7.6 million.

People and assets in 2025

Full-time equivalents

40.4

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 2.8 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 6.4 million

▼ 4% vs 2024

€ 157,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 105,816

▲ 52% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4.6 million

▲ 91% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 201 days on average.

Taxes and wages

€ 1.6 million

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 13,861,344 Revenue 2022: € 13,861,344 First fiscal year in the series	€ 13,088,032 Revenue 2023: € 13,088,032 ▼ 6% vs 2022 (€ 13,861,344) Unfavourable step	€ 13,242,214 Revenue 2024: € 13,242,214 ▲ 1% vs 2023 (€ 13,088,032) Favourable step	€ 12,721,310 Revenue 2025: € 12,721,310 ▼ 4% vs 2024 (€ 13,242,214) Unfavourable step	▼ 4%
Profit after taxes	€ 864,269 Profit after taxes 2022: € 864,269 First fiscal year in the series	€ 1,157,190 Profit after taxes 2023: € 1,157,190 ▲ 34% vs 2022 (€ 864,269) Favourable step	€ 1,111,415 Profit after taxes 2024: € 1,111,415 ▼ 4% vs 2023 (€ 1,157,190) Unfavourable step	€ 1,418,992 Profit after taxes 2025: € 1,418,992 ▲ 28% vs 2024 (€ 1,111,415) Favourable step	▲ 28%
Equity	€ 7,276,179 Equity 2022: € 7,276,179 First fiscal year in the series	€ 8,433,369 Equity 2023: € 8,433,369 ▲ 16% vs 2022 (€ 7,276,179) Favourable step	€ 9,544,784 Equity 2024: € 9,544,784 ▲ 13% vs 2023 (€ 8,433,369) Favourable step	€ 10,963,775 Equity 2025: € 10,963,775 ▲ 15% vs 2024 (€ 9,544,784) Favourable step	▲ 15%
Total debts	€ 5,861,191 Total debts 2022: € 5,861,191 First fiscal year in the series	€ 4,974,223 Total debts 2023: € 4,974,223 ▼ 15% vs 2022 (€ 5,861,191) Favourable step	€ 4,134,836 Total debts 2024: € 4,134,836 ▼ 17% vs 2023 (€ 4,974,223) Favourable step	€ 6,323,632 Total debts 2025: € 6,323,632 ▲ 53% vs 2024 (€ 4,134,836) Unfavourable step	▲ 53%
Cash	€ 211,463 Cash 2022: € 211,463 First fiscal year in the series	€ 67,061 Cash 2023: € 67,061 ▼ 68% vs 2022 (€ 211,463) Unfavourable step	-	-
Retained profit	€ 3,930,155 Retained profit 2022: € 3,930,155 First fiscal year in the series	€ 5,087,345 Retained profit 2023: € 5,087,345 ▲ 29% vs 2022 (€ 3,930,155) Favourable step	€ 6,198,760 Retained profit 2024: € 6,198,760 ▲ 22% vs 2023 (€ 5,087,345) Favourable step	€ 7,617,752 Retained profit 2025: € 7,617,752 ▲ 23% vs 2024 (€ 6,198,760) Favourable step	▲ 23%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 69,739 Bank debt 2024: € 69,739 Unchanged (€ 0) Unfavourable step	€ 105,816 Bank debt 2025: € 105,816 ▲ 52% vs 2024 (€ 69,739) Unfavourable step	▲ 52%
Balance sheet total	€ 13,137,370 Balance sheet total 2022: € 13,137,370 First fiscal year in the series	€ 13,407,592 Balance sheet total 2023: € 13,407,592 ▲ 2% vs 2022 (€ 13,137,370) Unchanged	€ 13,679,620 Balance sheet total 2024: € 13,679,620 ▲ 2% vs 2023 (€ 13,407,592) Unchanged	€ 17,307,089 Balance sheet total 2025: € 17,307,089 ▲ 27% vs 2024 (€ 13,679,620) Unchanged	▲ 27%
Employees (FTE)	42.7 Employees (FTE) 2022: 42.7 First fiscal year in the series	43 Employees (FTE) 2023: 43 ▲ 0.3 vs 2022 (42.7) Unchanged	39.6 Employees (FTE) 2024: 39.6 ▼ 3.4 vs 2023 (43) Unchanged	40.4 Employees (FTE) 2025: 40.4 ▲ 0.8 vs 2024 (39.6) Unchanged	▲ 0.8

Key figures of ORTHO - CLINICAL DIAGNOSTICS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ORTHO - CLINICAL DIAGNOSTICS?

What happened at ORTHO - CLINICAL DIAGNOSTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2032 Jürgen Naudts stepped down as director. NBB
2029 Salah Itani stepped down as director. NBB
2029 Mikael Julien stepped down as director. NBB
Aug 31, 2026 New annual accounts for financial year 2025: profit of € 1.4 million (▲ 28% vs 2024). filed late Source: NBB ↗
2026 Jürgen Naudts became a director. NBB
2026 Emmanuel Van de Wouwer stepped down as director. NBB
2024 Emmanuel Van de Wouwer became a director. NBB
2024 Salah Itani became a director. NBB

In short

From € 864,269 profit in 2022 to € 1.4 million profit in 2025.

Paid € 1.4 million in corporate taxes since 2022.

Best year ever: 2025, with € 1.4 million profit.

Original PDFs at the National Bank ↗

A new publication or filing at ORTHO - CLINICAL DIAGNOSTICS? We notify you, reason included.

Follow ORTHO - CLINICAL DIAGNOSTICS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Directors

According to the 2025 annual accounts

Jürgen Naudts

Director

since 2026 · until 2032

Emmanuel Van de Wouwer

Managing director

since 2024 · until 2026

Salah Itani

Director

since 2024 · until 2029

Mikael Julien

Managing director

since 2024 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Da Vincilaan 1

1930 Zaventem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 72 companies are registered at this address.

All companies at this address →

ALFA LAVAL BENELUX

€ 4.8 million gross margin · 2025

Association of Belgian Travel Organisers

FIRST STOP EUROPE

€ 8 million revenue · 2025

JOMIROU

€ -17,491 gross margin · 2024

BAYARD BENELUX

€ 1.9 million revenue · 2025

+67 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0419.897.954

VAT number

BE 0419.897.954

Registered office

Da Vincilaan 1, 1930 Zaventem

Names & denominations

ORTHO - CLINICAL DIAGNOSTICS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

12 November 1979

Peppol

Active · Active since 7 Oct 2025

Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Vervaardiging van elektrische apparaten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde

View on CBE Public ↗ Annual accounts (NBB) ↗